Approaches to the management of uncomplicated genital Chlamydia trachomatis infections.
Genital chlamydial infection remains a highly prevalent sexually transmitted infection in the USA. A multifaceted approach to the management of chlamydial infection is essential to ensure cure and prevention of reinfection. This article will review current approaches to the management of uncomplicated genital chlamydial infection, discussing: the pathogen; antimicrobials that are and are not recommended for therapy by the US Centers for Disease Control and Prevention; partner treatment; follow-up; antimicrobial resistance; and potential future therapies.
Geisler
William M
WM
University of Alabama, University of Alabama at Birmingham STD Program, 703 19th Street South, 242 Zeigler Research Building, Birmingham, AL 35249-0007, USA. wgeisler@uab.edu
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002487:Centers for Disease Control and Prevention, U.S.; D002690:Chlamydia Infections / Q000188:drug therapy* / Q000635:transmission; D002692:Chlamydia trachomatis; D002986:Clinical Trials as Topic; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D005832:Genital Diseases, Male / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012747:Sexual Partners; D014481:United States
D000900:Anti-Bacterial Agents